Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Lymphoid 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 1Lymphoma, Follicular 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1

Interventions

Specimen Handling 199Magnetic Resonance Spectroscopy 150Biopsy 121pembrolizumab 94Carboplatin 85Cisplatin 77Nivolumab 74Cyclophosphamide 70Paclitaxel 65Gemcitabine 53Radiotherapy 49Bevacizumab 45durvalumab 41Dexamethasone 39Fluorouracil 35Doxorubicin 35Capecitabine 35venetoclax 34olaparib 33atezolizumab 33Pemetrexed 33Injections 32Rituximab 31Oxaliplatin 31Radiation 29Prednisone 29Etoposide 29fludarabine 28Lenalidomide 28cemiplimab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Diphenhydramine × 30 days × Clear all
NCT05977998 2026-05-22

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled
Tumor-Agnostic

Carcinoma

NCT04165096 2026-05-13

MK-3475-01C

Merck Sharp & Dohme LLC

Phase 2 Completed
128 enrolled 14 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT06043323 2026-05-06

A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma

M.D. Anderson Cancer Center

Phase 2 Recruiting
20 enrolled
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡